| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 02/19/2008 | US7332301 Insulin-like growth factor binding protein |
| 02/19/2008 | US7332185 Component I selected from alpha acids and beta acids and component II selected from alpha acids, beta acids, essential oils, fats and waxes; specific inhibition of cyclooxygenase-2 with little effect on cyclooxygenase-1 |
| 02/19/2008 | CA2173976C Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 02/14/2008 | WO2008018447A1 Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
| 02/14/2008 | WO2008018427A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 02/14/2008 | WO2007018248A9 Pyridone compound |
| 02/14/2008 | WO2006024627A9 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/14/2008 | US20080039622 2,4-pyrimidinediamine compounds and their uses |
| 02/14/2008 | US20080039534 Methods for Identifying Modulators of RGS21 Activity, Compositions Comprising an RGS21 Modulator, and Methods of Use Thereof to Modulate Taste Sensation |
| 02/14/2008 | US20080039516 Composition of Solifenacin or Salt Thereof for Use in Solid Formulation |
| 02/14/2008 | US20080039507 Novel Prostamides For The Treatment Of Glaucoma And Related Diseases |
| 02/14/2008 | US20080039505 5-((((2R)-1-(4-((S)-1-hydroxyhexyl)phenyl)-4-methyl-5-oxopyrrolidin-2-yl)methoxy)methyl)thiophene-2-carboxylic acid; glaucoma or ocular hypertension |
| 02/14/2008 | US20080039451 Use of thiazole derivatives for preparing a medicament intended to protect the mitochondria |
| 02/14/2008 | US20080039423 Ophthalmic Composition Containing Xanthan Gum and Amino Acid |
| 02/14/2008 | US20080039398 Formulations and methods for treating dry eye |
| 02/14/2008 | US20080039380 Agent for Prophylactic and/or Therapeutic Treatment of Retinopathy |
| 02/14/2008 | US20080039378 Cyclosporin compositions |
| 02/14/2008 | US20080038372 Artificial Physiological Salt Solution and Manufacturing Method for Same |
| 02/14/2008 | US20080038358 Dry powder formulations of antihistamine for nasal administration |
| 02/14/2008 | US20080038317 Therapeutic Lacrimal Canalicular Inserts And Related Methods |
| 02/14/2008 | CA2659599A1 Amino alcohol derivative and immunosuppressive agent having same as an active ingredient |
| 02/14/2008 | CA2659598A1 Amino phosphate derivative and s1p receptor modulator having same as an active ingredient |
| 02/13/2008 | EP1887008A1 Thienotriazolodiazepine compound and a medicinal use thereof |
| 02/13/2008 | EP1885855A2 Cytokine receptor modulators and uses thereof |
| 02/13/2008 | EP1885371A1 Therapeutic compositions and methods |
| 02/13/2008 | EP1750735B1 Use of an extract of aloysia/verbrena/lippia triphylla/citridora for the preparation of a medicament for the treatment of chronic and/or inflammatory diseases |
| 02/13/2008 | EP1740203A4 Polypeptide inducing the secretion of angiopoietin |
| 02/13/2008 | EP1578915A4 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof |
| 02/13/2008 | EP1470148A4 Double-stranded oligonucleotides |
| 02/13/2008 | EP1463716B1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 02/13/2008 | EP1441701B1 Montelukast granule formulation |
| 02/13/2008 | EP1404650B1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 02/13/2008 | EP1289507B1 Use of an aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects |
| 02/13/2008 | CN101123948A 眼科用固体外用药剂 Topical ophthalmic pharmaceutical solid |
| 02/13/2008 | CN101121706A Coumarin derivatives, preparation method and use thereof |
| 02/13/2008 | CN101121012A Traditional Chinese medicine for treating external oculopathy eye disease |
| 02/13/2008 | CN100368021C Ophthalmological anti proliferative medicine containing sodium alginate micro gel bead and convex membrane and preparing method |
| 02/13/2008 | CN100367994C Medicinal preparation for treating deaf and preparing method |
| 02/13/2008 | CN100367972C Medicine for treating animal eyeball turbidness |
| 02/12/2008 | US7329782 Compounds for the treatment of metabolic disorders |
| 02/12/2008 | US7329777 Methods for treating heart failure, thromboembolic disorders, and pulmonary fibrosis |
| 02/12/2008 | US7329753 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 02/12/2008 | US7329686 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain |
| 02/12/2008 | US7329684 Modulators of the receptor for advanced glycated end products and interact with its ligands; antiinflammatory, antidiabetic and antitumor agents; Alzheimer's disease, erectile dysfunction, metastasis; 2-[(1R)-2-(4-Benzyloxyphenyl)-1-amino-1-ethyl]-3-butyl-5-(3-diethylamino-1-propoxy)benzimidazole |
| 02/12/2008 | US7329683 Moderation of cortisol; non-insulin dependent diabetes; hypotensive agents; using a 1,2,4 triazole compound |
| 02/12/2008 | US7329672 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 02/12/2008 | US7329671 N2,N4-bis(3-hydroxyphenyl)-5-fluoro-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 02/12/2008 | US7329660 Phthalazine derivatives for treating inflammatory diseases |
| 02/12/2008 | US7329651 Cannabimimetic ligands |
| 02/12/2008 | US7329500 Moraxella (Branhamella) catarrhalis polypeptides and corresponding DNA fragments |
| 02/12/2008 | US7329406 Methods of treating psoriasis with αvβ3-specific antibodies |
| 02/12/2008 | CA2402405C Compositions containing alpha-2-adrenergic agonist components |
| 02/12/2008 | CA2267543C Use of sulodexide and of the medicines containing it in the treatment of the diabetic retinopathy |
| 02/12/2008 | CA2133982C Ligand for the c-kit receptor and methods of use thereof |
| 02/12/2008 | CA2104699C Sustained release drug delivery devices |
| 02/07/2008 | WO2008016288A1 Benzimidazo[1,2-c][1,2,3]thiadiazol-7-sulfonamides as inhibitors of carbonic anhydrase and the intermediates for production thereof |
| 02/07/2008 | WO2008016132A1 Benzyl phenyl glucopyranoside derivative |
| 02/07/2008 | WO2008016095A1 PREVENTIVE OR REMEDY FOR KERATOCONJUNCTIVAL DISORDERS CONTAINING Nrf2 ACTIVATOR AS THE ACTIVE INGREDIENT |
| 02/07/2008 | WO2008016016A1 Aqueous liquid preparation containing amide compound |
| 02/07/2008 | WO2008016006A1 Compound having cyclic group bound thereto through spiro binding and use thereof |
| 02/07/2008 | WO2008015867A1 Method for activating and stabilizing dissolved hydrogen in water |
| 02/07/2008 | WO2008015517A2 Ep2 agonists |
| 02/07/2008 | WO2008014564A1 Methods and compositions for inhibiting angiogenesis |
| 02/07/2008 | WO2007135518A3 Use of choline-based preparations for the treatment of tinnitus |
| 02/07/2008 | US20080033170 Novel compounds |
| 02/07/2008 | US20080033165 2-(3-(2-phenyloxazolidin-4-on-3-yl)-4-(2-styryl)-azetidin-2-on-1-yl) alkanedioic acid derivatives and corresponding alkoxyalkanoic acid derivatives; treating psychological disorders, cardiovascular disorders |
| 02/07/2008 | US20080033053 Cross-Reference To Related Applications |
| 02/07/2008 | US20080033033 8-azaprostaglandin derivatives and medical use thereof |
| 02/07/2008 | US20080033028 Such as (+/-)-[9-(4-chlorobenzyl)-6-fluoro-8-methanesulfonyl-2, 3,4,9-tetrahydro-1H-carbazol-1-yl]acetic acid; prostaglandin receptor antagonists; antihistamines; nasal decongestion, rhinitis |
| 02/07/2008 | US20080032996 Substituted Quinazoline or Pyridopyrimidine Derivative |
| 02/07/2008 | US20080032981 Aryl n-cyanoguanidines and methods related thereto |
| 02/07/2008 | US20080032969 Novel compounds |
| 02/07/2008 | US20080032959 Estrogen Receptor Modulators |
| 02/07/2008 | US20080032951 Ophthalmic Compositions For Treating Ocular Hypertension |
| 02/07/2008 | US20080031884 Compositions and methods for treating, reducing, ameliorating, or alleviating posterior-segment ophthalmic diseases |
| 02/07/2008 | US20080031875 Treatment method |
| 02/07/2008 | CA2659687A1 Aqueous liquid preparation containing amide compound |
| 02/07/2008 | CA2659542A1 Methods and compositions for inhibiting angiogenesis |
| 02/07/2008 | CA2649044A1 Benzylphenyl glucopyranoside derivative |
| 02/06/2008 | EP1884237A1 Protective agent for neurocyte comprising amidino derivative as active ingredient |
| 02/06/2008 | EP1884236A1 Angiogenesis inhibitor containing amine derivative as active ingredient |
| 02/06/2008 | EP1884234A1 Prophylactic or therapeutic agent for corneal and conjunctival disorder |
| 02/06/2008 | EP1292619B1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/06/2008 | CN101117644A Diagnostics and therapeutics for glaucoma |
| 02/06/2008 | CN100366296C Process for preparing a sterile high molecular weight hyaluronic acid formulation |
| 02/06/2008 | CN100366254C Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases |
| 02/06/2008 | CN100366251C Organic compounds |
| 02/05/2008 | US7326803 Skin disorders; antiinflammatory agents; antiproliferative agents; controlling metabolism; obesity; antilipemic agents; antihistamines |
| 02/05/2008 | US7326801 2-amino-propanol derivatives |
| 02/05/2008 | US7326730 Aminoadamantane derivatives as therapeutic agents |
| 02/05/2008 | US7326723 Autoimmune disease; antiinflammatory agents |
| 02/05/2008 | US7326716 Treatment of inflammatory bowel disease |
| 02/05/2008 | US7326701 Lactam compounds and pharmaceutical use thereof |
| 02/05/2008 | US7326698 Prostaglandin analogs |
| 02/05/2008 | US7326696 Amino-methyl substituted tetracycline compounds |
| 02/05/2008 | US7326685 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 02/05/2008 | CA2436269C Artificial tear composition containing a combination of three demulcents |
| 02/05/2008 | CA2402686C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 01/31/2008 | WO2008014457A1 Monoamine oxidase inhibitors useful for treating disorders of the outer retina |
| 01/31/2008 | WO2008014456A2 Combination therapy for otitis with antiseptic and ph adjustment |